Product Description
PDLIM1 Antibody | 33-055 | ProSci
Host: Rabbit
Reactivity: Human
Homology: N/A
Immunogen: A recombinant protein fragment from human PDLIM1 was used as the immunogen for this antibody.
Research Area: Cancer, Obesity
Tested Application: WB
Application: Western blot: 1-3 ug/ml
Provided assay concentrations are suggestions only, antibody titration may be required for optimal results.
Specificiy: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: Protein A affinity chromatography
Clonality: Polyclonal
Clone: N/A
Isotype: IgG
Conjugate: Unconjugated
Physical State: Liquid
Buffer: PBS with 0.1 mg/ml BSA and 0.05% sodium azide
Concentration: 0.5 mg/mL
Storage Condition: Aliquot and Store at -20˚C. Avoid freez-thaw cycles.
Alternate Name: PDZ and LIM domain protein 1, C-terminal LIM domain protein 1, Elfin, LIM domain protein CLP-36, PDLIM1, CLIM1, CLP36
User Note: Optimal dilutions for each application to be determined by the researcher
BACKGROUND: PDLIM1 (PDZ And LIM Domain 1) is a member of the protein family Enigma and named for its amino terminal PDZ domain and carboxy terminal LIM domains. In breast cancer cells, PDLIM1 interacts with alpha actin 1 and 4, and is an important regulator of breast cancer cell migration and metastasis, but not proliferation. PDLIM1 is widely expressed, with high expression seen in muscle and heart, low expression in pancreas, thymus, liver and kidney, and no expression in testis, ovary and brain.